Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma. (2019)
Attributed to:
Clinical Translation of Gene Modified T-cell Therapy for Solid Tumours
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2019.00453
PubMed Identifier: 30941125
Publication URI: http://europepmc.org/abstract/MED/30941125
Type: Journal Article/Review
Volume: 10
Parent Publication: Frontiers in immunology
ISSN: 1664-3224